Business Wire

SEOUL-VIOSYS

3.3.2020 15:02:26 CET | Business Wire | Press release

Share
Seoul Viosys Sees Increased Demand for Its Violeds UV LED Technology for Sterilization Applications to Prevent the Spread of Coronavirus

Seoul Viosys , a leading global provider of UV LED technology and a subsidiary of Seoul Semiconductor, announced that customer inquiries for its violeds UV LED products, which are ideal for sterilizing bacteria, increased more than five times over the previous month, fueled by concerns over the continuing global spread of the coronavirus (COVID-19).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200303005072/en/

According to the Ultraviolet Germicidal Irradiation Handbook1 , one minute of UV-C light will sterilize more than 90% of the coronavirus. In addition, tests conducted by Chinese agencies on air appliances equipped with the violeds UV LED sterilization technology have demonstrated a 97% reduction in airborne virus particles.

With the growing concerns over the global spread of the coronavirus, numerous automotive companies in China are actively reviewing adoption of Seoul’s violeds UV LED technology in sterilization systems for vehicle interiors. In addition, violeds UV LED technology has been used by the US National Aeronautics and Space Administration (NASA) aboard the International Space Station (ISS) to provide a healthy, germ-free environment for astronauts.

Seoul’s violeds UV LED technology has been adopted by Maltani, the largest Korean lighting company, for sterilization lighting applications, and by RGF Environmental Group, the No.1 in-duct air treatment supplier in the U.S., for its [Halo-LED™] indoor air quality system launched in November of 2019, as shown in this YouTube video . In addition, violeds UV LEDs are used in water purifiers from SK Magic Co., Ltd. and Hyundai Rental Care Co., Ltd.

Until recently, many companies have been conservative in their adoption of UV LED technology because conventional UV LEDs typically had a short lifetime (10,000 hours) and high cost. However, Seoul Viosys recently improved the lifetime of their violeds UV LED to more than 50,000 hours, similar to visible LEDs used for general lighting applications, and increased production capacity to achieve cost competitiveness.

“Seoul Viosys is committed to developing technology that protects human health and creates a cleaner world, and we have long been involved in developing UV LEDs for innovative biomedical and agricultural applications,” said CEO Chung Hoon Lee, CEO of Seoul Semiconductor, which established Seoul Viosys 18 years ago to develop UV-LED technology in strategic partnerships with Japanese and U.S. companies. “Through innovation, sustained research and development, and manufacturing experience, we were able to improve the lifetime of UV LEDs up to 50,000 hours and significantly reduce product cost. We hope that Seoul’s violeds UV LED technology will help protect human health and create a cleaner world in the face of the current health situation.”

Seoul Viosys is currently run by its CEO Young joo Lee, who started the company in 2002.

1 Kowalski, W. 2009.Ultraviolet Germicidal Irradiation Handbook. Heidelberg, Germany: Springer-Verlag

About Seoul Viosys

Seoul Viosys is a full-line solution provider for UV LED, VCSEL (Vertical Cavity Surface Emitting Laser), the next-generation light source for 3D sensor and laser, and a single-pixel RGB “Micro Clean Pixel” for displays. Established in 2002 as a subsidiary of Seoul Semiconductor, it captured No. 1 market share in the UV LED industry (LEDinside, 2018). Seoul Viosys has an extensive UV LED portfolio with all wavelengths range (200nm to 1600nm) including ultraviolet rays (UV), visible rays and infrared rays. It holds more than 4,000 patents related to UV LED technology. Violeds, its flagship UV LED technology, provides a wide range of industries with optimal solutions for strong sterilization and disinfection (UVC), skin regeneration (UVB), water/air purification and effective cultivation for horticulture. In 2018, Seoul Viosys acquired RayCan, a leading optoelectronic specialist, to add the advanced VCSEL technology which supports smartphone facial recognition and autonomous driving, and has started its mass production. In January 2020, it introduced a disruptive “Micro Clean Pixel” that has the potential to be a game-changer in the display market. To learn more, visit http://www.seoulviosys.com/en/ .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

The Empire State Building Presents First-Ever Children’s Birthday Party Package for Celebrations at the Iconic Observatory Experience23.2.2026 15:13:00 CET | Press release

Express Access, Party Favors, and Private Room with Decorations and Ghirardelli Ice Cream Sundaes Parents who have looked for the best birthday party idea for their children have had their wish fulfilled. Today, the Empire State Building (ESB) announced the debut of its first-ever ESB Birthday Party Package for kids at the international icon’s Observatory as part of year-long 95th anniversary celebrations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260223161708/en/ The Empire State Building Presents First-Ever Children’s Birthday Party Package for Celebrations at the Iconic Observatory Experience “From Lego playtime to Percy Jackson readers, children love the Empire State Building and now parents can give an unmatched experience to their children and their friends,” said Anthony E. Malkin, chairman and CEO of Empire State Realty Trust. “This birthday party package tops them all with an escorted visit through our world-fa

Xsolla Co-Sponsors Gamescom Dev Leadership Summit in Lisbon, Bringing Together Gaming Industry Leaders to Shape the Future of Game Development23.2.2026 15:00:00 CET | Press release

Platform Supporting 1,500+ Game Developers Across 200+ Geographies to Host Networking Dinner and Co-Moderate Strategic Roundtable at Premier European Gaming Executive Summit Xsolla, a global video game commerce company that helps developers launch, grow, and monetize their games, today announced its co-sponsorship of the Gamescom Dev Leadership Summit Lisbon, taking place February 24-26 at SUD Lisboa in Portugal. The event brings together gaming industry executives, studio founders, and business leaders to explore opportunities and innovations shaping the future of game development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260223253705/en/ Graphic: Xsolla As part of its sponsorship, Xsolla will host the summit's Wednesday evening networking dinner and co-moderate a strategic roundtable session focused on business models and sustainable growth in the gaming industry. "We're seeing incredible innovation from studios acro

CoolMPS™ 600: Accurate and Affordable Long MPS/NGS Reads on a Mid-Throughput Platform23.2.2026 15:00:00 CET | Press release

Swiss Rockets AG announces that its CoolMPS 600 mid-throughput sequencer with advanced chemistry and novel MPS/NGS read length will become available in Q2 2026. Enabled by its exclusive license of CoolMPS technology, Swiss Rockets AG is developing its first sequencer, CoolMPS 600, through contract R&D with Complete Genomics since August 2025. The platform is utilizing the company’s proprietary antibody-based CoolMPS™ chemistry combined with DNBSEQ™, a real PCR-free DNA nanoarray technology. Separately, Swiss Rockets AG announced that it has entered into a definitive agreement to acquire 100% ownership of Complete Genomics. CoolMPS 600 enables cost-effective extended single-end sequencing to 600 bases (SE600) while maintaining high base accuracy. The system is designed to support advanced whole-genome sequencing (WGS) with improved mapping accuracy across complex genomic regions, including better detection of structural variants. It also enables full length transcriptomes and more infor

Angelini Pharma and Quiver Bioscience Announce Strategic Research Collaboration and Licensing Agreement to Discover and Advance Novel Therapeutics for Genetic Epilepsies23.2.2026 14:08:00 CET | Press release

Angelini Pharma secures exclusive global license rights to future identified drug targets Quiver receives undisclosed advance payment and is eligible for future milestone-dependent payments and royalties Collaboration further expands Angelini Pharma’s focus on brain health, building on its deep therapeutic expertise and drug development experience Angelini Pharma, part of the privately owned Angelini Industries, and Quiver Bioscience (“Quiver”), a discovery technology and therapeutics company advancing programs for the treatment of central nervous system (CNS) disorders, announced today that they have entered into a collaboration and licensing agreement to advance novel therapeutics for genetic epilepsies. The collaboration brings together Quiver’s unique drug discovery capabilities, data assets, and AI models with Angelini Pharma’s established expertise in brain health and epilepsy drug development. This press release features multimedia. View the full release here: https://www.busine

Armis Achieves U.S. Department of Defense Impact Level 5 Authorization23.2.2026 14:00:00 CET | Press release

DoD customers can now leverage Armis Centrix™ with enhanced security controls and connectivity Armis, the cyber exposure management & security company, today announced that it has achieved authorization from the U.S. DoD’s Defense Information Systems Agency (DISA) to operate at an Impact Level 5 (IL5). This means that Armis has met strict requirements to manage and secure the DoD’s critical infrastructure, including Controlled Unclassified Information (CUI) systems. “We are committed to helping Federal agencies like the Department of Defense address their toughest cybersecurity challenges,” said Alex Mosher, President and CRO at Armis. “Achieving DISA IL5 authorization is an important milestone for Armis as we continue to support DoD customers in safeguarding critical systems, sensitive data and national security infrastructure from evolving cyber threats.” Armis empowers Federal agencies to build and optimize comprehensive cybersecurity programs with Armis Centrix™, the FedRAMP and DI

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye